Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Chirea (RAMNICU SARAT/BUZAU, Romania). Systemic inflammation, blood eosinophils count and lung function in COPD patients. 1106

Member's Comments

No comment yet.

Related content which might interest you: FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD Source: Eur Respir J 2016; 47:1562-1564 Year: 2016 Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Airway neutrophilia in COPD is not associated with increased neutrophil survival Source: Eur Respir J 2006; 28: 1163-1169 Year: 2006 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study Source: International Congress 2016 – Systemic biomarkers Year: 2016 Associations between blood eosinophils and decline in lung function among adults with and without asthma Source: Eur Respir J, 51 (4) 1702536; 10.1183/13993003.02536-2017 Year: 2018 Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005 Effect of dupilumab on severe exacerbations and lung function in patients with baseline blood eosinophils =500 cells/µL Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Blood eosinophils do not reflect lung tissue eosinophils in COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Effect of echinochrome on the respiratory burst of blood polymorphonuclear neutrophils in pediatric patients with interstitial lung disease (ILD): an in vitro study. Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 Interpreting blood eosinophil counts in health and obstructive lung disease Source: Eur Respir J, 59 (1) 2102180; 10.1183/13993003.02180-2021 Year: 2022 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017